For example: Apple Inc, UTIL, Aluminum
NantKwest Inc
NASDAQ:NK
Market Close 11/27
9.67 USD +2.13 (+28.25%)
OPEN:
7.57
DAY RANGE:
7.56 - 9.75
PE:
-1.12
PB:
0.63
PS:
1,676.12
WTD % 16.23
MTD % 28.76
QTD % 39.44
YTD % 155.15
* Updated at market close
NantKwest Inc (NASDAQ:NK) opened on Nov 27, 2020 at 7.57 USD and increased exponentially by 28.25%. The intraday price range was 7.56 - 9.75 USD and eventually ended the session at 9.67 USD. The stock trade volume was 1.89 M shares. The company's 52-week range is 1.35 - 15.70 USD.
Trading Statistics (Market Close Nov 27, 2020)
Market Cap 1.04 B
Outstanding Stock 79.23 M
Dividend 0.00
Dividend Yield 0.00
EPS -0.91
YTD Change 155.15%
52 Week's Range 1.35 - 15.70
Key Ratio & Margins (Market Close Nov 27, 2020)
Price/Earning -1.12
Price/Book Value 0.63
Price/Sales 1,676.12
ROA -
ROE -
Debt/Equity 0.16
Company Self Description
NantKwest, Inc. develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States. The company develops activated natural killer cell, a natural killer cell-line and genetically modified derivative capable of killing cancer and virally infected cells; and NANT cancer vaccine, a personalized therapy that utilizes its off-the-shelf natural killer cells. It was founded in 2002 and is headquartered in San Diego, California, United States.
Business Information
NantKwest Inc
Sector Health Care
Industry Biotechnology
Exchange NASDAQ
Top Competitors (Market Close Nov 27, 2020)
  NK AKRO ALEC CLLS
Daily Change (%) 28.25 1.32 0 7.98
WTD (%) 16.23 1.04 5.23 14.47
MTD (%) 28.76 10.09 41.23 52.17
QTD (%) 39.44 -5.07 26.15 30.86
YTD (%) 155.15 31.70 -22.87 41.41
52-Week Change (%) 532.03 52.16 -29.76 72.68
Stock Performance (Market Close Nov 27, 2020)
  NK AKRO ALEC CLLS
Daily Change (%) 28.25 1.32 0 7.98
WTD (%) 16.23 1.04 5.23 14.47
MTD (%) 28.76 10.09 41.23 52.17
QTD (%) 39.44 -5.07 26.15 30.86
YTD (%) 155.15 31.70 -22.87 41.41
52-Week Change (%) 532.03 52.16 -29.76 72.68
Key Fundamentals (Market Close Nov 27, 2020)
  NK AKRO ALEC CLLS
Market Cap 1.04 B 1.01 B 1.05 B 1.03 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -125,903.30% 0.00 0.00 -367.20%
P/E Ratio -1.12 0 0 -7.51
Price to Sales Ratio 1,676.12 0 0 24.30
Price to Book Ratio 0.63 0 0 1.27
Enterprise Value to EBITDA -0.95 0 0 -3.44
ROA - 0 0 -18.90%
ROE - 0 0 -23.30%
Debt/Equity 0.16 -0.05 -2.01 0.12
Asset Turnover Ratio 0.00 0 0 0.05
Current Ratio 3.26 32.93 6.11 10.40
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 47,000.00 45,000.00 44,000.00 236,000.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 47,000.00 45,000.00 44,000.00 236,000.00
Selling General & Administrative Expenses 42.72 M 57.12 M 95.39 M 227.68 M
Research & Development 55.72 M 42.04 M 29.15 M 11.43 M
Operating Income -98.39 M -99.12 M -124.50 M -238.88 M
Net Income -96.23 M -96.42 M -120.81 M -236.88 M
EPS -1.22 -1.20 -1.47 -3.31
Diluted EPS -1.22 -1.20 -1.47 -3.31
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 17,000.00 5,000.00 7,000.00 31,000.00
Cost Of Revenue 0.00 0.00 0.00 0.00
Gross Profit 17,000.00 5,000.00 7,000.00 31,000.00
Selling General & Administrative Expenses 4.18 M 5.74 M 5.25 M 9.58 M
Research & Development 13.13 M 12.60 M 12.48 M 14.56 M
Operating Income -17.30 M -18.34 M -17.72 M -24.11 M
Net Income -16.68 M -17.89 M -17.34 M -23.64 M
EPS -0.17 -0.22 -0.22 -0.30
Diluted EPS -0.17 -0.22 -0.22 -0.30
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 88.77 M 132.46 M 205.15 M 297.54 M
Cash & Cash Equivalents 16.82 M 23.87 M 8.08 M 175.91 M
Total Assets 181.95 M 250.44 M 317.50 M 366.85 M
Total Current Liabilities 27.26 M 20.87 M 12.55 M 6.15 M
Total Liabilities 35.94 M 31.60 M 24.08 M 10.85 M
Shareholder's Equity 146.01 M 218.84 M 293.42 M 356.00 M
Outstanding Stock 79.23 M 79.46 M 82.38 M 81.22 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 87.05 M 113.43 M 88.77 M 100.57 M
Cash & Cash Equivalents 17.53 M 23.48 M 16.82 M 15.31 M
Total Assets 175.70 M 208.26 M 181.95 M 201.64 M
Total Current Liabilities 12.43 M 27.70 M 27.26 M 30.40 M
Total Liabilities 24.43 M 40.45 M 35.94 M 39.56 M
Shareholder's Equity 151.27 M 167.81 M 146.01 M 162.09 M
Outstanding Stock 98.67 M 79.09 M 79.23 M 79.21 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -63.38 M -48.78 M -38.59 M -25.31 M
Capital Expenditures -12.69 M -34.82 M -6.56 M -2.24 M
Net Cash Flow from Investing Activities 57.10 M 99.55 M -113.67 M -175.22 M
Net Cash Flow from Financial Activities -771,000.00 -34.98 M -15.56 M 317.33 M
Free Cash Flow -76.07 M -83.60 M -45.15 M -27.55 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -16.83 M -48.78 M -38.59 M -25.31 M
Capital Expenditures -985,000.00 -2.10 M -1.65 M -3.64 M
Net Cash Flow from Investing Activities 11.38 M -19.46 M 15.91 M 16.87 M
Net Cash Flow from Financial Activities -501,000.00 39.20 M -370,000.00 -115,000.00
Free Cash Flow -17.81 M -15.18 M -15.69 M -21.21 M
Key Ratios (Market Close Nov 27, 2020)
Valuation Ratios 2020 2019 2018 2017
P/E Ratio -1.12 -1.45 -0.95 -2.82
Price to Sales Ratio 1,676.12 2,731.77 1,953.06 5,635.69
Price to Book Ratio 0.63 1.63 1.61 3.95
Enterprise Value to EBIT -1.00 -4.00 -4.00 -4.00
Enterprise Value to EBITDA -0.95 -3.72 -3.76 -4.45
Profitability Ratios 2020 2019 2018 2017
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - -46.70% -34.00%
ROE - - -55.80% -39.00%
Liquidity Ratios 2020 2019 2018 2017
Working Capital 61.51 M 111.59 M 192.59 M 291.39 M
Current Ratio 3.26 6.35 16.34 48.40
Efficiency & Capital Structure Ratios 2020 2019 2018 2017
Debt Equity Ratio 0.16 0.14 0.08 0.03
Asset Turnover Ratio - - 0.00 0.00
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.